chuminhua2020-08-17 15:56
8月17日,赛诺菲(Sanofi)$赛诺菲-安万特(SNY)$ 和Principia Biopharma$Principia Biopharma(PRNB)$ (一家专注于开发免疫介导疾病治疗方法的后期生物医药公司)达成最终收购协议,交易总额约36.8亿美元。赛诺菲和Principia董事会一致批准了这笔交易。通过此次收购,赛诺菲获得Principia在研的3款...查看全文
chuminhua2020-07-18 16:28
7/16,一名熟悉内情的匿名人士告诉彭博社,Sanofi$赛诺菲-安万特(SNY)$ 正准备斥资500亿美元用于收购交易,重点是生物技术公司和治疗多发性硬化症及免疫疾病的资产。据传闻,主要目标是CNS和免疫学生物技术公司Principia Biopharma$Principia Biopharma(PRNB)$ ,两家公司已经建立了合作伙伴关系。...查看全文
资本主义拉美行不通2020-07-18 13:50
$Principia Biopharma(PRNB)$ 来神棍一把,Principia Biopharma, a Sanofi Company, 周一买入查看全文
牛唐2019-11-12 22:02
$Ovid Therapeutics(OVID)$又一个 没发数据就增发,学$Principia Biopharma(PRNB)$ 的吗,害怕数据不好
$Karyopharm(KPTI)$查看全文
chuminhua2019-10-12 10:39
10/11,在与AbbVie分手数月后,Principia $Principia Biopharma(PRNB)$ 宣布BTK抑制剂PRN1008用于寻常型天疱疮de II期开放标签试验B部分的数据。15名入组患者中,6名完全康复,4名仍在治疗,9名患者达到PDAI评分0或1。A部分研究时间是12周,B部分为24周,完全康复的比例从25%增至40%。PRN1008于201...查看全文
淘沙见金2018-09-15 01:48
$Principia Biopharma(PRNB)$ 做口服BTK抑制剂的小分子公司。IPO定价17,八月份刚刚发行的C轮价格 $14.38,IPO第一天股价轻松翻倍。今年做生物医药VC真是不错查看全文
$Principia Biopharma(PRNB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-052227 Size: 20 KB 网页链接
$Principia Biopharma(PRNB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-052224 Size: 25 KB 网页链接
$Principia Biopharma(PRNB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-052225 Size: 16 KB 网页链接
$Principia Biopharma(PRNB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-052222 Size: 32 KB 网页链接
$Principia Biopharma(PRNB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-052223 Size: 26 KB 网页链接
$Principia Biopharma(PRNB)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-255655 Act: 33 Size: 20 KB 网页链接
$Principia Biopharma(PRNB)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-255650 Act: 33 Size: 20 KB 网页链接
$Principia Biopharma(PRNB)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-255653 Act: 33 Size: 20 KB 网页链接
$Principia Biopharma(PRNB)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-20-255644 Act: 33 Size: 19 KB 网页链接
$Principia Biopharma(PRNB)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-20-000530 Act: 34 Size: 2 KB 网页链接